Benzopyrimido‐pyrrolo‐oxazine‐dione CFTR inhibitor (R)‐BPO‐27 for antisecretory therapy of diarrheas caused by bacterial enterotoxins
暂无分享,去创建一个
A. Verkman | M. Donowitz | Jianyi Yin | N. Zachos | A. Gillespie | R. Lin | Lukmanee Tradtrantip | Sujin Lee | P. Phuan | M. Tse | O. Cil | Onur Cil
[1] Chun-Ming Lin,et al. Evolution, antigenicity and pathogenicity of global porcine epidemic diarrhea virus strains , 2016, Virus Research.
[2] M. Dransfield,et al. Therapeutic Approaches to Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction in Chronic Bronchitis. , 2016, Annals of the American Thoracic Society.
[3] Olga Kovbasnjuk,et al. Human Enteroids as a Model of Upper Small Intestinal Ion Transport Physiology and Pathophysiology. , 2016, Gastroenterology.
[4] A. Verkman,et al. Small‐molecule CFTR activators increase tear secretion and prevent experimental dry eye disease , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] T. Ma,et al. CFTR Activator Increases Intestinal Fluid Secretion and Normalizes Stool Output in a Mouse Model of Constipation , 2016, Cellular and molecular gastroenterology and hepatology.
[6] B. Mock,et al. Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression , 2015, ACS chemical biology.
[7] M. Helmrath,et al. Drug-induced secretory diarrhea: A role for CFTR. , 2015, Pharmacological research.
[8] S. Marshall,et al. Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors , 2015, Pediatric pulmonology.
[9] Min Goo Lee,et al. Benzopyrimido-pyrrolo-oxazine-dione (R)-BPO-27 Inhibits CFTR Chloride Channel Gating by Competition with ATP , 2015, Molecular Pharmacology.
[10] Y. Tseng,et al. Synthesis and inhibitory effects of novel pyrimido-pyrrolo-quinoxalinedione analogues targeting nucleoproteins of influenza A virus H1N1. , 2015, European journal of medicinal chemistry.
[11] Alan S. Verkman,et al. Secretory diarrhoea: mechanisms and emerging therapies , 2015, Nature Reviews Gastroenterology &Hepatology.
[12] Hong Yang,et al. Oridonin: a small molecule inhibitor of cystic fibrosis transmembrane conductance regulator (CFTR) isolated from traditional Chinese medicine. , 2015, Fitoterapia.
[13] A. Verkman,et al. Antidiarrheal Efficacy and Cellular Mechanisms of a Thai Herbal Remedy , 2014, PLoS neglected tropical diseases.
[14] T. Ma,et al. Chloride channel inhibition by a red wine extract and a synthetic small molecule prevents rotaviral secretory diarrhoea in neonatal mice , 2013, Gut.
[15] J. Fettinger,et al. ABSOLUTE CONFIGURATION AND BIOLOGICAL PROPERTIES OF ENANTIOMERS OF CFTR INHIBITOR BPO-27. , 2013, ACS medicinal chemistry letters.
[16] A. Verkman,et al. Convective washout reduces the antidiarrheal efficacy of enterocyte surface–targeted antisecretory drugs , 2013, The Journal of general physiology.
[17] A. Verkman,et al. CFTR inhibitors. , 2013, Current pharmaceutical design.
[18] L. Frye,et al. Locating a Plausible Binding Site for an Open-Channel Blocker, GlyH-101, in the Pore of the Cystic Fibrosis Transmembrane Conductance Regulator , 2012, Molecular Pharmacology.
[19] S. Soodvilai,et al. Antidiarrheal efficacy of a quinazolin CFTR inhibitor on human intestinal epithelial cell and in mouse model of cholera , 2012, Indian journal of pharmacology.
[20] S. Levy,et al. Familial diarrhea syndrome caused by an activating GUCY2C mutation. , 2012, The New England journal of medicine.
[21] F. Gottrand,et al. The management of acute diarrhea in children in developed and developing areas: from evidence base to clinical practice , 2012, Expert opinion on pharmacotherapy.
[22] D. Sheppard,et al. Therapeutic Potential of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitors in Polycystic Kidney Disease , 2012, BioDrugs.
[23] R. Choy,et al. Developing novel antisecretory drugs to treat infectious diarrhea. , 2011, Future medicinal chemistry.
[24] A. Verkman,et al. Potent, metabolically stable benzopyrimido-pyrrolo-oxazine-dione (BPO) CFTR inhibitors for polycystic kidney disease. , 2011, Journal of medicinal chemistry.
[25] Tzyh-Chang Hwang,et al. On the mechanism of CFTR inhibition by a thiazolidinone derivative , 2010, The Journal of general physiology.
[26] A. Verkman,et al. TMEM16A Inhibitors Reveal TMEM16A as a Minor Component of Calcium-activated Chloride Channel Conductance in Airway and Intestinal Epithelial Cells* , 2010, The Journal of Biological Chemistry.
[27] S. Moore,et al. Prolonged episodes of acute diarrhea reduce growth and increase risk of persistent diarrhea in children. , 2010, Gastroenterology.
[28] A. Verkman,et al. CFTR-Adenylyl Cyclase I Association Responsible for UTP Activation of CFTR in Well-Differentiated Primary Human Bronchial Cell Cultures , 2010, Molecular biology of the cell.
[29] Robert E Black,et al. The effect of oral rehydration solution and recommended home fluids on diarrhoea mortality , 2010, International journal of epidemiology.
[30] M. Ao,et al. Ion transport in the small intestine , 2010, Current opinion in gastroenterology.
[31] S. Walker,et al. Development of improved inhibitors of wall teichoic acid biosynthesis with potent activity against Staphylococcus aureus. , 2010, Bioorganic & medicinal chemistry letters.
[32] A S Verkman,et al. Crofelemer, an Antisecretory Antidiarrheal Proanthocyanidin Oligomer Extracted from Croton lechleri, Targets Two Distinct Intestinal Chloride Channels , 2010, Molecular Pharmacology.
[33] W. Guggino,et al. Epac1 mediates protein kinase A–independent mechanism of forskolin-activated intestinal chloride secretion , 2009, The Journal of general physiology.
[34] A S Verkman,et al. Nanomolar potency pyrimido-pyrrolo-quinoxalinedione CFTR inhibitor reduces cyst size in a polycystic kidney disease model. , 2009, Journal of medicinal chemistry.
[35] Alan S. Verkman,et al. Chloride channels as drug targets , 2009, Nature Reviews Drug Discovery.
[36] L. Galietta,et al. Nanomolar CFTR inhibition by pore-occluding divalent polyethylene glycol-malonic acid hydrazides. , 2008, Chemistry & biology.
[37] R. Ravazzolo,et al. Evidence for direct CFTR inhibition by CFTR(inh)-172 based on Arg347 mutagenesis. , 2008, The Biochemical journal.
[38] A S Verkman,et al. Small-molecule CFTR inhibitors slow cyst growth in polycystic kidney disease. , 2008, Journal of the American Society of Nephrology : JASN.
[39] L. Galietta,et al. Lectin conjugates as potent, nonabsorbable CFTR inhibitors for reducing intestinal fluid secretion in cholera. , 2007, Gastroenterology.
[40] David N Sheppard,et al. The relationship between cell proliferation, Cl- secretion, and renal cyst growth: a study using CFTR inhibitors. , 2004, Kidney international.
[41] A. Taddei,et al. Discovery of Glycine Hydrazide Pore-occluding CFTR Inhibitors , 2004, The Journal of general physiology.
[42] C. Flexner,et al. Diarrhea-associated HIV-1 APIs potentiate muscarinic activation of Cl- secretion by T84 cells via prolongation of cytosolic Ca2+ signaling. , 2004, American journal of physiology. Cell physiology.
[43] A. Verkman,et al. Prevention of toxin-induced intestinal ion and fluid secretion by a small-molecule CFTR inhibitor. , 2004, Gastroenterology.
[44] Hong Yang,et al. Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion. , 2002, The Journal of clinical investigation.
[45] R. Prasad,et al. Evidence for the presence of cGMP-dependent protein kinase-II in human distal colon and in T84, the colonic cell line. , 2000, Biochimica et biophysica acta.
[46] M. Estes,et al. NSP4 elicits age-dependent diarrhea and Ca2+mediated I- influx into intestinal crypts of CF mice. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[47] M. Estes,et al. NSP4 elicits age-dependent diarrhea and Ca(2+)mediated I(-) influx into intestinal crypts of CF mice. , 1999, The American journal of physiology.
[48] L. Rome,et al. The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro. , 1996, Kidney international.
[49] F.J. Sauvage,et al. Activation of intestinal CFTR Cl‐ channel by heat‐stable enterotoxin and guanylin via cAMP‐dependent protein kinase. , 1994, EMBO Journal.
[50] H. Mekhjian,et al. VIPoma syndrome. , 1987, Seminars in oncology.
[51] J. Rask-Madsen,et al. Prostaglandin E2-mediated secretory diarrhea in villous adenoma of rectum: effect of treatment with indomethacin. , 1981, Gastroenterology.
[52] M. Field. Mechanisms of action of cholera and Escherichia coli enterotoxins. , 1979, The American journal of clinical nutrition.